about
Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki diseaseTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesDesign of a superior cytokine antagonist for topical ophthalmic useGraves' ophthalmopathyDrug Repositioning through Systematic Mining of Gene Coexpression Networks in CancerEffects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseasesThe detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Interleukin-1β causes fluoxetine resistance in an animal model of epilepsy-associated depression.Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.A genomic approach to human autoimmune diseases.An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking StatusFcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy.Rationale of using different biological therapies in rheumatoid arthritis.A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritisCytokine-modulating strategies and newer cytokine targets for arthritis therapy.IL-1β and IL-18: inflammatory markers or mediators of hypertension?Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.Interleukin-1 and acute brain injury.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesExperimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literatureFunctional role for interleukin-1 in the injured peripheral taste system.Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection.Transforming Growth Factor-β and Interleukin-1β Signaling Pathways Converge on the Chemokine CCL20 Promoter.Therapy of autoinflammatory syndromes.Are biological agents toxic to human chondrocytes and osteocytes?Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplantPopulation pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis.Autolytic proteolysis within the function to find domain (FIIND) is required for NLRP1 inflammasome activity.Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.Radiation damage and radioprotectants: new concepts in the era of molecular medicineTherapeutic targeting of the inflammome.Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Uric acid as a danger signal in gout and its comorbiditiesHigh incidence of tuberculosis infection in rheumatic diseases and impact for chemoprophylactic prevention of tuberculosis activation during biologics therapyLong-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes.
P2860
Q24633011-8ADBF162-B4A3-4B5E-A4AC-DFCEA5AD177AQ26799747-17E5BE31-E4A5-4E7F-9FF5-7CF65457FEAEQ27676526-89773EFC-652D-4012-B6A9-70F11D7A4747Q28274196-B4991842-F8C1-42D0-BB83-28183F81AA71Q28553245-AB856C89-363D-4502-8234-52110EFEB52CQ28744267-8E6D4B3D-BA23-4C70-81A1-FC3B94093ADAQ30497355-D173231B-4938-406B-8AAC-FD485229AA7CQ30513801-DF3AF8EB-30DF-47EC-A45E-1573D7CBDD68Q31039549-66A5DB52-FB32-40C1-B699-15B076FC6AE5Q33762839-A1D32FD8-73C4-42E9-A0FB-3E974D9F43C2Q33769541-9BDFF312-3106-4E64-B178-B69E908F0318Q33848529-E38488FD-1366-42A9-B9A0-E5FDCDD6F6BFQ33992811-C636CDE2-275D-47E8-A90C-D6A0986BC600Q34123499-604A61BF-46DB-41EE-83DE-BEBC362BE039Q34153073-5503AB70-CD8B-47A7-A872-96EDB063BFF7Q34346378-6F44C645-E92A-4B28-AA3D-4E4FDF565F2EQ34456715-25E7A0AC-DE49-4F6C-A963-83F89E4FE8BCQ34914125-271259B4-982B-4259-B093-0C2E9F3422C7Q35028032-96147F93-7D6A-43E0-B8EE-72E9C692DB9CQ35056860-D2F7C28A-E58C-4EE8-BE46-00F78DC6C3BEQ35133812-B41215C6-1253-43E3-BAE6-D32FB5C3374CQ35589934-6ACD8807-F20D-40BE-ACE1-0BAD589F65E7Q35687532-980B971C-79B1-462F-B2D4-6974E7059B22Q35742815-8B561BE6-CED8-45B6-8D35-000C09E65D23Q35833796-1CBAA4E1-83F6-48AF-BB23-3A239085B408Q35860853-8828DBBB-AAD5-47ED-ABCA-87EAB02A180EQ35868028-3EDB25F4-3245-4976-B9D6-DF85431D3D0CQ35903134-2B03B5A2-1205-4F56-A224-4F37392CBF09Q36026239-7B1C4233-C00A-4BEE-8805-DA6F19562FD3Q36090184-73F08C28-269E-4B38-A8D8-3AABF0BE14D2Q36125978-AA68B837-B3F4-4E3D-8778-360902E12506Q36127206-FD948EFB-6A31-42C3-8E88-0678060DDD2CQ36344968-DFC49E29-B36E-424A-87F7-59C539013D3CQ36364394-8AAFB22A-9E71-43B8-AE46-6ABC204B1866Q36490256-2D6E214A-B9AA-4282-BCC3-EDECC93F7B43Q36546979-6EC5C27F-1DD1-4295-8DBA-1C7EAFFB267FQ36816872-D31F6648-F86B-44A8-AFAA-C973F47FF514Q36829387-5E13B685-2477-48C1-8B2E-5C5C7B971D2AQ36911254-7413FA3D-026D-46A1-9488-070D756F0BC6Q37118963-035A26D9-F74C-43B3-8C01-F04A53C7D191
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anakinra for rheumatoid arthritis: a systematic review.
@en
Anakinra for rheumatoid arthritis: a systematic review.
@nl
type
label
Anakinra for rheumatoid arthritis: a systematic review.
@en
Anakinra for rheumatoid arthritis: a systematic review.
@nl
prefLabel
Anakinra for rheumatoid arthritis: a systematic review.
@en
Anakinra for rheumatoid arthritis: a systematic review.
@nl
P356
P1476
Anakinra for rheumatoid arthritis: a systematic review.
@en
P2093
Marty Mertens
P304
P356
10.3899/JRHEUM.090074
P407
P577
2009-05-15T00:00:00Z